Zymeworks Inc. · NASDAQ:ZYME
Moore Paul Andrew sold 39,741 Zymeworks Inc. shares (Form 4)
Traded Nov 13, 2026 · Filed Nov 16, 2026
On Nov 13, 2026, Moore Paul Andrew (Chief Scientific Officer) sold 39,741 Zymeworks Inc. shares at an average US$26.07 for US$1.04M, leaving 33,756 shares. Filed Nov 16, 2026 (Form 4).
- Sold
- 39,741 shares
- Price
- US$26.07 average (US$26.04 to US$26.14)
- Value
- US$1.04M
- Holding after
- 33,756 shares
- Trading plan
- No
- Role
- Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | Common Stock | Option exercise | 25,000 | US$5.82 | 73,497 | Direct |
| Nov 13, 2026 | Common Stock | Sale | 7,367 | US$26.14 | 66,130 | Direct |
| Nov 13, 2026 | Common Stock | Sale | 7,374 | US$26.09 | 58,756 | Direct |
| Nov 13, 2026 | Common Stock | Sale | 25,000 | US$26.04 | 33,756 | Direct |
Source
Download original · View original at SEC